Aardvark Therapeutics, Inc. (AARD)
3.76
-0.02
(-0.53%)
USD |
NASDAQ |
Oct 19, 16:00
3.81
+0.05
(+1.33%)
After-Hours: 20:00
Aardvark Therapeutics EPS Diluted (Quarterly) : -0.6586 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6586 |
| March 31, 2026 | -0.9896 |
| December 31, 2025 | -0.8067 |
| September 30, 2025 | -0.7503 |
| June 30, 2025 | -0.6623 |
| March 31, 2025 | -0.4293 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.4046 |
| September 30, 2024 | -0.1956 |
| June 30, 2024 | -2.128 |
| March 31, 2024 | -0.8507 |
| December 31, 2023 | -0.0954 |
| September 30, 2023 | -0.0986 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.39M |
| Total Expenses (Quarterly) | 14.39M |
| Enterprise Value | 9.529M |
| Earnings Yield | -85.24% |
| Normalized Earnings Yield | -85.25 |